This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Acanya Gel

Valeant Pharmaceuticals International, Inc.

Drug Names(s): clindamycin phosphate 1.2% and benzoyl peroxide 2.5%

Description: Acanya Gel is a combination product that contains 1% clindamycin (clindamycin phosphate 1.2%) and benzoyl peroxide 2.5%. Clindamycin is an antibiotic with the activity against the Propionibacterium acnes (P acnes). Bezoyl peroxide is an antibacterial agent that is active against P acnes based on its oxidizing properties.

Another formulation of this product, Onexton (clindamycin phosphate 1.2% and benzoyl peroxide 3.75%), was approved in 2014.

Deal Structure: Acanya Gel was originally developed by Dow Pharmaceutical Sciences.

In December 2008, Valeant announced that it has signed a definitive agreement to acquire Dow Pharmaceutical Sciences. Dow Pharmaceutical will operate as a wholly owned subsidiary of Valeant.

Acanya Gel News

Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug